Table 2.
Characteristics of participants according to TG/HDL-C ratio > 3.0 cut-off point
| TG/HDL-C ratio | p-Value | |||
| <3.0 (62.8%) | ≥3.0 (37.2%) | |||
| Age (years) | 52.4 ± 5.9 | 52.2 ± 5.6 | NS | |
| Weight (kg) | 67.6 ± 12 | 70.9 ± 13 | 0.045 | |
| Body Mass Index (Kg/m2) | 28.2 ± 4.9 | 29.9 ± 5.1 | ||
| Normal | 26.4% | 19.1% | 0.009 | |
| Overweight | 43.4% | 32.0% | 0.012 | |
| Obesity | 30.2% | 48.9% | ||
| Waist (cm) | 90.4 ± 11.5 | 95 ± 12.1 | 0.003 | |
| Visceral Adipose Tissue (cm2) | 132.7 ± 59.2 | 148.1 ± 54.2 | 0.041 | |
| Total Fat (%) | 37.5 ± 4.8 | 38 ± 5.1 | NS | |
| Systolic Blood Pressure (mmHg) | 111.1 ± 13.4 | 112.8 ± 15.1 | NS | |
| Diastolic Blood Pressure (mmHg) | 74.8 ± 9.2 | 75.2 ± 9.3 | NS | |
| Glucose (mg/dL) | 83.3 ± 18.6 | 92.6 ± 20 | ||
| Normal Glucose | 93.7% | 76.6% | <0.001 | |
| Impaired Fasting Glucose | 6.3% | 23.4.% | <0.001 | |
| HbA1c (%) | 5.4 ± 0.4 | 5.6 ± 0.3 | ||
| <5.7 | 67.1% | 58.7% | 0.044 | |
| (5.7-6.4) | 32.9% | 41.3% | 0.184 | |
| Insulin (mU/L)* | 15.9 (12.1 - 22.5) | 19.9 (15.4 - 29.6) | <0.001 | |
| HOMA-IR* | 3.2 (2.3 - 4.7) | 4.4 (3.1 - 6.8) | ||
| Normal | 46.5% | 20.9% | <0.001 | |
| Insulin Resistance | 53.5% | 79.1% | <0.001 | |
| Triglycerides (mg/dL)* | 118 (94 - 142) | 209 (177 - 257.5) | <0.001 | |
| Total Cholesterol (mg/dL) | 233.3 ± 47.2 | 234.3 ± 49.1 | NS | |
| HDL–C (mg/dL) | 61.3 ± 13.2 | 44.4 ± 11.5 | <0.001 | |
| LDL–C (mg/dL) | 147 ± 43.6 | 143.3 ± 41.6 | NS | |
| cIMT (mm) | 0.69 ± 0.10 | 0.7 ± 0.11 | ||
| Normal Risk | 51.9% | 36.8% | NS | |
| High Risk | 48.1% | 63.2% | 0.81 | |
HOMA-IR, homeostasis model assessment of insulin resistance; cIMT, Carotid intima-media thickness. Parametric variables are represented as mean and standard deviation.
*
Non-parametric variables are represented as median and interquartile range.